Financhill
Back

Trevi Therapeutics Stock Price Chart

  • The current trend is moderately bullish and TRVI is experiencing selling pressure, which indicates risk of future bearish movement.

Trevi Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 4.17 Sell
20-day SMA: 3.35 Buy
50-day SMA: 3.15 Buy
200-day SMA: 2.98 Buy
8-day EMA: 3.95 Buy
20-day EMA: 3.56 Buy
50-day EMA: 3.26 Buy
200-day EMA: 2.91 Buy

Trevi Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 63.29 Buy
Chaikin Money Flow: -255608 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.59 - 3.91) Buy
Bollinger Bands (100): (2.7 - 3.48) Buy

Trevi Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Trevi Therapeutics Stock

Is Trevi Therapeutics Stock a Buy?

TRVI Technical Analysis vs Fundamental Analysis

Sell
49
Trevi Therapeutics (TRVI) is a Sell

Is Trevi Therapeutics a Buy or a Sell?

Trevi Therapeutics Stock Info

Market Cap:
307.5M
Price in USD:
4.00
Share Volume:
441.5K

Trevi Therapeutics 52-Week Range

52-Week High:
4.68
52-Week Low:
1.27
Sell
49
Trevi Therapeutics (TRVI) is a Sell

Trevi Therapeutics Share Price Forecast

Is Trevi Therapeutics Stock a Buy?

  • Trevi Therapeutics share price is 4.00 while TRVI 8-day exponential moving average is 3.95, which is a Buy signal.
  • The stock price of TRVI is 4.00 while Trevi Therapeutics 20-day EMA is 3.56, which makes it a Buy.
  • Trevi Therapeutics 50-day exponential moving average is 3.26 while TRVI share price is 4.00, making it a Buy technically.
  • TRVI stock price is 4.00 and Trevi Therapeutics 200-day simple moving average is 2.91, creating a Buy signal.

Fundamental Analysis of Trevi Therapeutics

Is Trevi Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.00 per share.

Technical Analysis of Trevi Therapeutics

Should I short Trevi Therapeutics stock?

* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.